INVIVO THERAPEUTICS HOLDINGS CORP. 4
4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Mar 4, 2015
Insider Transaction Report
Form 4
Lorianne Masuoka K.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-03-02+500,000→ 500,000 totalExercise: $3.02Exp: 2025-03-02→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.